Because germline mutations in BRCA1 and BRCA2 greatly increase a woman’s risk of developing breast and/or ovarian cancer, and the prevalence and distribution of the germline mutations differ in different races/ethnicities, we were interested in identifying the full spectrum of these mutations in high-risk female breast cancer patients in the Chinese population. This evidence concerns the gene BRCA2 and breast carcinoma.